Apolipoprotein E and α1-antichymotrypsin genotypes and age of onset of familial Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue 1, 1999, Pages 1-5

  Axelman, Karin ^a   Basun, Hans ^a,b   Lannfelt, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Astra Arcus AB   (Sweden)

Author keywords

1 antichymotrypsin; Age of onset; Apolipoprotein E; Familial Alzheimer's disease

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; SIBLING; ALLELE; CLINICAL TRIAL; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED;

EID: 0032589677     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017090     Document Type: Article

References (35)

1. Mullan M, Tsuli S, Miki T, Katsuya T, Naruse S, Kaneko K, Shimizu T, Kojima T, Nakano I, Ogihara T, Miyatake T, Ovenstone I, Crawford F, Clark C, Gaskell P, Crain B, Roses A: Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val → Ile mutation in the amyloid precursor protein gene. Neurobiol Aging 1993;14:407-419.
2. van Duijn C, van Broeckhoven C, Hardy J, Goate A, Rossor M, Vandenberghe A, Martin J, Hofman A, Mullan M: Evidence for allelic heterogeneity in familial early-onset Alzheimer's disease. Br J Psychiatry 1991;158:471-474.
3. Kennedy AM, Newman S, McCaddon A, Ball J, Roques P, Mullan M, Hardy J, Chartier Harlin M-C, Frachowiak RSJ, Warrington EK, Rossor M: Familial Alzheimer's disease: A Pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine→glycine). Brain 1993;116: 309-324.
4. Axelman K, Basun H, Winblad B, Lannfelt L: A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation: A clinical and genealogical investigation. Arch Neurol 1994;51:1193-1197.
5. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
6. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Albert MJ, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
8. Lannfelt L, Lilius L, Nastase N, Viitanen M, Fratiglione L, Eggertsen G, Berglund L, Angelin B, Linder J, Winblad B, Basun H: Lack of association between apolipoprotein E allele ε4 and sporadic Alzheimer's disease. Neurosci Lett 1994;169:175-178.
9. Basun H, Grut M, Winblad B, Lannfelt L: Apolipoprotein ε4 and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lettt 1995;183:32-34.
10. Locke PA, Coneally PM, Tanzi RE, Gusella JF, Haines JL: Apolipoprotein E4 allele and Alzheimer's disease: Examination of allelic association and effect on age at onset in both early-and late-onset cases. Genet Epidemiol 1995;12: 83-92.
11. Lehtovirta M, Helisalmi S, Mannermaa A, Soininen H, Koivisto K, Ryynänen M, Riekkinen P Sr: Apolipoprotein E polymorphism and Alzheimer's disease in Eastern Finland. Neurosci Lett 1995;185:13-15.
12. van Broeckhoven C, Backhovens H, Cruts M, Martin JJ: APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994;169:179-180.
13. Levy-Lahad E, Lahad A, Wijsman E, Bird TD, Schellenberg GD: Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Ann Neurol 1995;38:678-680.
14. Abraham CR, Shirahama T, Potter H: Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Neurobiol Aging 1990;11:123-129.
15. 1-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem 1993;61:298-305.
16. Eriksson S, Janciauskiene S, Lannfelt L: α1-Antichymotrypsin regulates amyloid fibril formation from the Alzheimer β-amyloid peptide. Proc Natl Acad Sci USA 1995;92:2313-2317.
17. Kamboh MI, Sanghera DK, Ferrel RE, DeKosky ST: APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat Genet 1995;10:486-488.
18. Corder EH, Basun H, Lilius L, Corder LS, Viitanen M, Winblad B, Lannfelt L: Alzheimer's disease risk in relation to α1-antichymotrypsin and apolipoprotein E polymorphism in very old adults above 75+. Alzheimer's Res 1996;2: 51-54.
19. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskall PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BC, Yamaoka L, Small GW, Coneally PM, Roses AD, Pericak-Vance MA: No genetic effect of α1-antichymotrypsin in Alzheimer's disease. Genomics 1996;33:53-56.
20. Nacmias B, Tedde A, Latorraca S, Piacentini S, Bracco L, Amaducci L, Guarnieri BM, Petruzzi C, Ortenzi L, Sorbi S: Apolipoprotein E and α1-antichymotrypsin polymorphism in Alzheimer's disease. Ann Neurol 1996;40:678-680.
21. Talbot C, Houlden H, Craddock N, Crook R, Hutton M, Lendon C, Prihar G, Morris JC, Hardy J, Goate A: Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. Neuroreport 1996;7:534-536.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
23. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet 1992;1:345-347.
24. Alzheimer's Disease Collaborative Group: The structure of the presenilin I (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995;11:219-222.
25. Forsell C, Froelich S, Axelman K, Vestling M, Cowburn R, Lilius L, Johnston J, Engvall B, Johansson K, Dahlkild Å, Ingelson M, St George-Hyslope P, Lannfelt L: A novel pathogenic mutation (Leu26Phe) found in the presenilin 1 gene in early-onset Alzheimer's disease. Neurosci Lett 1997;234:3-6.
26. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, Winblad B, Viitanen M: Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996;27:1310-1315.
27. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L: Apolipoprotein E polymorphism in a healthy Swedish population: Variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993; 39:2125-2129.
28. Houlden H, Crook R, Hardy J, Roques P, Collinge J, Rossor M: Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci Lett 1994;174:222-224.
29. Forsell C, Lannfelt L: Amyloid precursor protein mutation at codon 713 (Ala→Val) does not cause schizophrenia: Non-pathogenic variant found at codon 705 (silent). Neurosci Lett 1995;184:90-93.
30. Corder EH, Basun H, Lannfelt L, Viitanen M, Winblad B: Attenuation of apolipoprotein E ε4 allele gene dose effect in late age. Lancet 1996; 347:542.
31. Mayeaux R, Stern Y, Ottman R, Talemichi T, Tang MX, Maestre G, Ngai C, Tycko B, Ginsberg H: The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34: 752-754.
32. Corder EH, Lannfell L, Corder LS, Viitanen M, Winblad B, Basun H: Apolipoprotein E influences survival in the oldest-old who have intact cognition. Arch Neurol 1996;53:418-422
33. Blacker D, Haines JL, Rodes L, Terwedow H, Go RCP, Harell LE, Perry RT, Bassett SS, Chase G, Meyers D, Albert MS, Tanzi R: ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative. Neurology 1997;48:139-147.
34. van Duijn C, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, van Broeckhoven C: Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78.
35. Räihä I, Kaprio J, Koskenvuo M, Rajala T, Sourander L: Alzheimer's disease in Finnish twins. Lancet 1996;347:573-578.